FridayAug 17, 2012 10:54 am

Teletouch Communications, Inc. (TLLE) Sells Two-Way Radio Business, Focuses on Broader Cellular and Electronics Distribution

With its start as a Motorola Service Station in east Texas, Teletouch and its predecessor companies have been known for nearly a half century as providers of two-way radio products and services, eventually including cellular, GPS-telemetry, and wireless messaging, and operating a chain of 11 retail and authorized agent stores in North and Central Texas. Today, with its developing presence as a cellular and electronics wholesale distributor, the company has chosen to divest its two-way radio division. Yesterday, Teletouch announced the sale of its two-way radio and public safety equipment business unit for approximately $1.5 million to DFW Communications, Inc.,…

Continue Reading

FridayAug 17, 2012 8:45 am

Arotech Corp. (ARTX) Subsidiary Awarded Contract to Supply National Guard Driving Simulators

FAAC, a subsidiary of Arotech, recently announced that the company has been awarded a $6.1 million contract to supply the Army National Guard with Military Operator Driving Simulators (ODS). Under the terms of the contract, FAAC will supply eight trailer systems to the National Guard. Arotech is focused on developing and manufacturing simulation-based training systems as well as multimedia and interactive digital solutions for use in engineering, use-of-force, and driver training simulations for military, law enforcement, security, municipal, and private industry personnel. The National Guard locations receiving the simulators are Arizona, Indiana, Kansas, Kentucky, Massachusetts, South Dakota, and Nevada. Each…

Continue Reading

ThursdayAug 16, 2012 3:42 pm

TG Therapeutics, Inc. (TGTX) and Rhizen Pharmaceuticals Announce Partnership to Co-Develop and Commercialize TGR-1202

TG Therapeutics is a clinical-stage biopharm company whose strategy is to acquire, develop, and commercialize pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. In line with this strategy, TG and Rhizen Pharmaceuticals S A today announced their exclusive global agreement to co-develop and commercialize Rhizen's lead product candidate, TGR-1202. "We are excited to enter into this collaboration with Rhizen Pharmaceuticals, whose innovative pre-clinical development program has yielded an impressive portfolio of PI3K delta inhibitors that we are eager to advance into development," Michael S. Weiss, executive chairman and Interim CEO of TG stated in the press…

Continue Reading

ThursdayAug 16, 2012 3:21 pm

Silver Bull Resources, Inc. (SVBL) Renews Mitzic License, Reports on Extensive Iron Ore Correlated by Recent Work Program

Silver Bull Resources, the Canadian mineral exploration firm primarily focused on their flagship Sierra Mojada (silver, zinc, and lead) project in Mexico, reported some really good news today out of their 1,243 sq. mile Mitzic site, which is on the western edge of the region’s major iron belt (three deposits greater than 650 metric tonnes at 60% Fe currently under development), in the French-speaking West-Central African democracy of Gabon – as the Gabonese Ministry of Mines renewed the site license for another three years. In addition, the company offered a pertinent status update from the work program conducted on the…

Continue Reading

ThursdayAug 16, 2012 2:32 pm

Oncolytics Biotech, Inc. (ONCY) Completes Patient Enrollment in UK Phase I Trial of REOLYSIN

Canadian-based Oncolytics Biotech is focused on the novel approach of developing oncolytic viruses as potential therapeutics for patients afflicted with various types of cancer, including lung, pancreatic, and colorectal cancers. The company's clinical program includes a Phase III trial in head and neck cancer using REOLYSIN, its proprietary formulation of the human reovirus. The company today announced that it has completed its 36 patient enrollment in its U.K. Phase I clinical trial using intravenously-administered REOLYSIN in combination with cyclophosphamide in patients with advanced malignancies. Eligible patients include those who have been diagnosed with advanced or metastatic solid tumors. These include…

Continue Reading

ThursdayAug 16, 2012 9:00 am

USA Technologies, Inc. (USAT) Announces Entrance into Mobile Payment Acceptance Market

USA Technologies yesterday introduced ePort Mobile™, an innovative product giving retailers and other merchants the capability of accepting credit and debit cards in a mobile environment through USAT’s highly secure, turnkey ePort Connect® service platform. USAT will leverage its extensive experience, over fifteen years, in transitioning traditionally cash-based, unattended retail businesses to cashless payments to make an efficient, effective entry into the multibillion-dollar mobile payments acceptance market. ePort Mobile will offer: • Three levels of data security – credit card data is encrypted twice and is transmitted using a proprietary communication protocol; • Durable, industrial grade card magnetic swipe reader…

Continue Reading

ThursdayAug 16, 2012 8:44 am

World-Renowned Scientists Join International Stem Cell Corp. (ISCO) as Advisors on Parkinson’s Disease Program

Today before the opening bell, International Stem Cell Corp., a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products, announced that Professor Evan Snyder and Dr. Rosasio Sánchez-Pernaute are now scientific advisors on the company’s Parkinson's disease program. Evan Snyder, MD, PhD is a Professor at the Sanford-Burnham Medical Research Institute and director of Sanford-Burnham's stem cell program and research center. Regarded as one of the pioneers of stem cell research, particularly with regard to regenerative medicine applications, Prof. Snyder is an expert on…

Continue Reading

WednesdayAug 15, 2012 3:40 pm

Tanke BioSciences Corp. (TNBI) Turns to Profit in Q2 2012; Announces Sales Increases in Quarterly and Six-Month Results

Tanke BioSciences, a China-based agritech company, today announced its financial results for the second quarter and first six months of 2012, reporting a quarterly turn-to-profit and a 49 percent improvement in sales vs. the second quarter of last year. Tanke recorded net income of $272,411, or $0.01 per share, compared to a loss of $1.65 million, or a loss of $0.12 per share, in the second quarter of 2011. Revenues for the 2012 quarter came in at $7.43 million vs. revenues of $4.98 million in the comparable quarter of the year prior. For the first six months ended June 30,…

Continue Reading

WednesdayAug 15, 2012 3:11 pm

Skinny Nutritional Corp. (SKNY) to Get the Message Across and Grab Consumers with New Packaging

When it comes to consumer goods, one of the most important forms of product advertising has nothing to do with television, billboards, or social media. It’s the product packaging. Developing product packaging to present a clear and unique message to the consumer is one of the most effective ways to get them to buy. Why go to all the trouble of getting hard-to-win shelf space for your product and not use it to maximum advantage? Think about it: The consumer is already in the store or other point of sale, they are already thinking of buying something, and they will…

Continue Reading

WednesdayAug 15, 2012 1:33 pm

Duma Energy Corp. (DUMA) and the African Connection

When Duma Energy, an aggressively growing Houston-based oil and gas exploration and production company, recently announced an agreement to acquire Namibia Exploration, Inc., a company that holds the rights to a 39% working interest in an onshore petroleum concession of roughly 5.3 million acres in northern Namibia on Africa’s southwest coast, it represented a major step forward. Until this time, Duma had focused on domestic oil and gas, with major production coming from off-shore wells in the shallow waters of Galveston Bay and Trinity Bay near Houston, Texas. But Duma’s African acquisition did not diverge from the company’s clearly stated…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered